NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund a number of research centers over the next two years with grants supporting translational research projects that focus on cancers of specific organs.

Funded through its Specialized Programs of Research Excellence (SPORE) program, NCI will fund between 16 and 24 awards that will conduct projects focused on improving early detection, diagnosis, prevention, and treatment of these cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.